Finance

Lists
S1YK34:BVMF
Stryker Corp Bdr
R$86.42
0.00%
(0.00) 1D
Aug 4, 4:56:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for S1YK34...
Open
R$86.42
High
R$86.42
Low
R$86.42
Mkt. cap
128.87B
Avg. vol.
1.07K
Volume
12.57K
52-wk high
R$106.64
52-wk low
R$69.65
Shares outstanding
383.57M
No. of employees
56K
Open
R$86.42
High
R$86.42
Low
R$86.42
Mkt. cap
128.87B
Avg. vol.
1.07K
Volume
12.57K
52-wk high
R$106.64
52-wk low
R$69.65
Shares outstanding
383.57M
No. of employees
56K
News stories
From sources across the web
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States. The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp Bdr
CEOKevin A. Lobo
Employees56K
Founded1941
HeadquartersKalamazoo, Michigan, United States
SectorMedical device
Websitestryker.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.06B
7.17B
6.02B
6.59B
Cost of goods sold
2.12B
2.49B
2.19B
2.08B
Cost of revenue
2.12B
2.49B
2.19B
2.08B
Research and development expenses
409.00M
388.00M
409.00M
429.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.99B
2.15B
2.16B
2.13B
Operating expense
2.58B
2.72B
2.75B
2.73B
Total operating expenses
4.71B
5.22B
4.95B
4.81B
Operating income
1.35B
1.95B
1.07B
1.78B
Other non operating income
-138.00M
541.00M
19.00M
1.00M
EBT including unusual items
1.03B
1.70B
850.00M
1.56B
EBT excluding unusual items
1.25B
1.81B
987.00M
1.68B
Income tax expense
170.00M
856.00M
105.00M
288.00M
Effective tax rate
16.52%
50.21%
12.35%
18.41%
Other operating expenses
-
-
-
-
Net income
859.00M
849.00M
745.00M
1.28B
Net profit margin
14.18%
11.84%
12.38%
19.37%
Earnings per share
3.19
4.47
2.60
3.69
Interest and investment income
28.00M
-
34.00M
26.00M
Interest expense
-
-697.00M
-148.00M
-141.00M
Net interest expenses
28.00M
-697.00M
-114.00M
-115.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.66B
2.27B
1.37B
2.08B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps